Novavax Inc
Change company Symbol lookup
Select an option...
NVAX Novavax Inc
MRK Merck & Co Inc
HYT BlackRock Corporate High Yield Fund, Inc
FNMA Federal National Mortgage Association
CPKF Chesapeake Financial Shares Inc
AGNC Agnc Investment Corp
BYND Beyond Meat Inc
NDENF Central African Gold Inc
HD Home Depot Inc
ACPS AC Partners Inc

Health Care : Biotechnology | Mid Cap Value
Company profile

Novavax, Inc. is a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants. The Company operates through developing recombinant vaccines segment. The Company, through its recombinant nanoparticle vaccine technology, produces vaccine candidates to respond to both known and newly emerging diseases. The Company's product pipeline focuses on a range of infectious diseases with vaccine candidates in clinical development for respiratory syncytial virus (RSV), seasonal influenza, pandemic influenza and the Ebola virus (EBOV). The Company's lead adjuvant for human applications, Matrix-M, is in a Phase I/II clinical trial for pandemic influenza H7N9 vaccine candidate. It is also testing Matrix-M in conjunction with its EBOV vaccine candidate in a Phase I clinical trial. It is developing additional pre-clinical stage programs in a range of infectious diseases, including Middle East respiratory syndrome (MERS).

Closing Price
Day's Change
-4.99 (-4.66%)
B/A Size
Day's High
Day's Low

10-day average volume:

5 stocks for the next 10 years -- some picks are obvious, others not so much

2:53 pm ET October 12, 2020 (MarketWatch)

By Shawn Langlois

'You have to put all your money into 5 stocks and hold it for 10 years, what are you buying and why?'

"You have to put all your money into 5 stocks and hold it for 10 years, what are you buying and why?" In Reddit's "Stocks" community (, an investor going by the name 7thAccountDontDelete posed that question to the group's nearly 900,000 members over the weekend.

The answers ranged from the obvious internet chat room favorites, like Tesla (TSLA) , Microsoft (MSFT) and other Big Tech names that dominate the headlines, to some more obscure picks, such as Nio (NIO) and Bio-Rad (BIO).

Mrmrmrj643 drew the most upvotes with his take, explaining that it is extremely rare, if it has ever even happened, that the winners of a previous decade remain the same for the following decade.

"In the 80s, big pharma did very well. In the 90s, they did not. Tech hardware did very well. Then tech hardware crashed and housing and commodities led the way," he wrote. "For the last 10 years, software and internet media have dominated, but the kings are likely established now."

He said he believes genetic therapy and genomics could very well deliver the next big explosive move in the stock market. "Find companies between $1 billion and $20 billion mkt cap and spread your money across them," he said, pointing to the likes of Invitae (NVTA), NanoString Technologies (NSTG) , Thermo Fisher Scientific (TMO) as his top picks.

Other areas carrying high expectations from the group for 2020 and beyond include cloud computing, clean energy, artificial intelligence and online gaming, to name just a few.

One "Stocks" member by the name of AugustinCauchy summed up the entire discussion with this word cloud of the 1,100-plus comments:

As you can see, Microsoft, Apple (AAPL) and Tesla led the way, with Amazon (AMZN) , AMD (AMD) , Walmart (WMT) and Alibaba (9988.HK) also popping up.

High-profile tech names were having a strong Monday run, as the Nasdaq Composite started the week on a high note. The Dow Jones Industrial Average and S&P 500 were also firmly in the green.

What are your five picks for the next 10 years? Share in the comments.

-Shawn Langlois; 415-439-6400;

(END) Dow Jones Newswires

October 12, 2020 14:53 ET (18:53 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.